Lobular in-situ neoplasia on breast core needle biopsy: Imaging indication and pathologic extent can identify which patients require excisional biopsy

Annals of Surgical Oncology

Volumn 19, Issue 3, 2012, Pages 914-921

  Rendi, Mara H ^a   Dintzis, Suzanne M ^a   Lehman, Constance D ^a,b   Calhoun, Kristine E ^a,b   Allison, Kimberly H ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATYPICAL LOBULAR HYPERPLASIA; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; CARCINOMA IN SITU; DIAGNOSTIC IMAGING; EXCISION; EXCISIONAL BIOPSY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERPLASIA; LOBULAR CARCINOMA IN SITU; LOBULAR IN SITU NEOPLASIA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; ULTRASOUND; ADULT; AGED; BREAST TUMOR; ECHOMAMMOGRAPHY; FEMALE; LUNG CARCINOMA; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; HYPERPLASIA; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; ULTRASONOGRAPHY, MAMMARY;

EID: 84862264387     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2034-3     Document Type: Article

References (41)

1. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17:491-6.
2. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737-69. (Pubitemid 8406608)
3. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ. Am J Surg Pathol. 2005;29:1685-6.
4. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-708. (Pubitemid 15092160)
5. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232-9.
6. Page DL, Dupont WD, Rogers LW. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term followup study of cancer risk. Hum Pathol. 1988;19:201-7. (Pubitemid 18091028)
7. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361(9352):125-9. (Pubitemid 36092016)
8. Lakhani SR. In-situ lobular neoplasia: time for an awakening. Lancet. 2003;361 (9352):96. (Pubitemid 36092008)
9. Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer. 2006;42: 2205-11.
10. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2:225-51. (Pubitemid 9093683)
11. Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979;189:377-82. (Pubitemid 9137913)
12. Vogel VG, Costantino JP, Wickerham DL, et al. Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention trials. J Natl Cancer Inst Monogr. 2010;41:181-6.
13. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-88. (Pubitemid 28439961)
14. Venkitaraman R. Lobular neoplasia of the breast. Breast J. 2010;16:519-28.
15. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Clin Breast Cancer. 2002;3:153-9.
16. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001;218:503-9. (Pubitemid 32121066)
17. Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy - clinical significance. Cancer. 2004;101:242-50. (Pubitemid 38890825)
18. Chikman B, Lavy R, Davidson T, et al. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast. Isr Med Assoc J. 2010;12:697-700.
19. Anderson E, Berg J, Black R, et al. Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold. Br J Cancer. 2008;98:840-4. (Pubitemid 351272601)
20. Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM. Lobular neoplasia on core needle biopsy does not require excision. Cancer. 2008;112:2152-8. (Pubitemid 351628623)
21. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173:291-9. (Pubitemid 29347344)
22. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000;216:831-7. (Pubitemid 30660861)
23. D'Orsi CJ, Mendelson EB, Ikeda DM. ACR breast imaging and reporting data system: breast imaging atlas. Reston: American College of Radiology; 2003.
24. Wang LC, DeMartini WB, Partridge SC, Peacock S, Lehman CD. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol. 2009;193:826-31.
25. Eby PR, Lehman CD. Magnetic resonance imaging-guided breast interventions. Top Magn Reson Imaging. 2008;19:151-62.
26. Page DL, Anderson TJ. Diagnostic histopathology of the breast. New York: Churchill Livingstone; 1987.
27. Rosen PP. Rosen's breast pathology. Philadelphia: Lippincott Williams & Wilkins; 2001.
28. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15:1044-50.
29. Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003;16:120-9. (Pubitemid 36245743)
30. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 2006;187:949-54. (Pubitemid 44453948)
31. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004;231:813-9. (Pubitemid 38668103)
32. Brem RF, Lechner MC, Jackman RJ, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 2008;190:637-41. (Pubitemid 351304506)
33. Menon S, Porter GJ, Evans AJ, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch. 2008;452:473-9.
34. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002;126:697-701. (Pubitemid 34602571)
35. Crisi GM, Mandavilli S, Cronin E, Ricci A Jr. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol. 2003;27:325-33. (Pubitemid 36245797)
36. Hwang H, Barke LD, Mendelson EB, Susnik B. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 2008;21:1208-16.
37. Esserman LE, Lamea L, Tanev S, Poppiti R. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J. 2007;13:55-61. (Pubitemid 46046494)
38. Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med. 2008;132:979-83. (Pubitemid 351918705)
39. Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med. 2003;127:49-54. (Pubitemid 36236579)
40. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002;117:797-9. (Pubitemid 34457017)
41. Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 2007;14:1051-7.